Millions of Drivers Take Hay Fever Tablets Every Summer Without Knowing They Could Lead to Prosecution

Around 18 million people in the UK suffer from hay fever, and millions of them reach for an antihistamine tablet every day during the summer months. What many do not realise is that certain hay fever medications can impair driving ability to a degree that leaves the driver at risk of prosecution under the same laws that govern drink and drug driving.

The legal position is clear. Under the Road Traffic Act 1988, it is an offence to drive a vehicle on a road when your ability to do so is impaired by any drug or medication, whether that medication was prescribed, bought over the counter, or taken for a completely legitimate purpose such as treating a seasonal allergy. The law does not make an exception for legal medicines.

With grass pollen counts at their highest between June and September, and August representing peak allergy season for many sufferers, the risk of impaired driving linked to hay fever medication is at its greatest right now.

Which Medications Create the Problem?

Not all hay fever tablets carry the same risk. Antihistamines fall broadly into two categories: first-generation and second-generation. The distinction is important for drivers.

First-generation antihistamines, which include chlorphenamine (sold as Piriton) and promethazine (sold as Phenergan), are well established as causing significant drowsiness. These are the original antihistamine formulations and they cross the blood-brain barrier relatively easily, causing sedation that is a recognised and expected side effect. Taking a first-generation antihistamine before driving is broadly considered inadvisable by medical professionals, pharmacists and road safety organisations alike.

Second-generation antihistamines were developed specifically to reduce the drowsiness problem. Drugs in this category include cetirizine (sold under various brand names including Benadryl), loratadine (Clarityn), fexofenadine (Telfast) and acrivastine (Benadryl Allergy Relief). These are marketed as “non-drowsy” formulations, and for many people they produce no noticeable sedation at all.

However, the “non-drowsy” label is not a guarantee. A proportion of people taking second-generation antihistamines do experience drowsiness, and the NHS is explicit that even non-drowsy formulations can affect some individuals. The patient information leaflet inside most antihistamine packets includes a specific warning about driving, advising users to see how the medication affects them before getting behind the wheel.

What Does the Law Actually Say?

There are two separate legal frameworks that can apply to a driver affected by medication.

The first is Section 4 of the Road Traffic Act 1988, which covers driving while unfit through drugs. This is a broad offence that applies to any drug, legal or otherwise, if it impairs the driver’s ability to control the vehicle safely. It is the provision most likely to apply to a driver whose hay fever medication has left them too drowsy to drive safely.

The second is Section 5A of the same Act, which covers driving above specified legal limits for certain drugs. The drugs listed under Section 5A are mostly illicit substances, though some prescription medicines are included. Standard over-the-counter antihistamines are not on the Section 5A list, which means the roadside drug swab test used by police will not detect them. However, this does not protect a driver from prosecution under Section 4 if a police officer assesses them as impaired.

A conviction under Section 4 for driving while unfit through drugs carries a minimum twelve-month driving ban, an unlimited fine, up to six months in prison and between three and eleven penalty points. The offence appears on a driver’s record for eleven years. The consequences are not minor.

How Police Assess Medication Impairment

When a police officer suspects a driver of being impaired by medication, they do not rely on a blood test or a breath test. They apply what is known as a field impairment test, which assesses coordination, balance, pupil response and other physical indicators. If the driver fails those assessments, they can be arrested and taken for a clinical assessment at a police station.

Unlike the roadside drug swabs used to detect cannabis, cocaine and other controlled substances, there is no roadside test specifically for antihistamines or other common over-the-counter medicines. However, police do not need a positive swab to make an arrest under Section 4. Observable impairment is sufficient.

Officers are trained to identify signs of medication impairment including slurred speech, poor coordination, slower reaction times, reduced awareness and drowsiness. Drivers who appear obviously drowsy at the wheel, particularly following a stop or collision, are routinely assessed for drug impairment regardless of whether alcohol is suspected.

The Scale of the Problem

Data from the Department for Transport indicates that drug-impaired driving, including impairment by legal medication, is a significant contributor to road casualties in the UK. In recent years the number of casualties where drugs, including legal medicines, were recorded as a factor has risen as testing and awareness both increase.

A survey conducted by GEM Motoring Assist found that a substantial proportion of drivers either did not know that hay fever medication could impair driving, or assumed that products labelled “non-drowsy” were safe to take before driving without any individual assessment. Road safety specialists have repeatedly described this as a knowledge gap that leaves well-intentioned drivers exposed to prosecution.

Allergy UK estimates that around 18 million people in the UK have allergic rhinitis, commonly called hay fever, making it one of the most prevalent health conditions in the country. In summer months, the overlap between the millions of hay fever sufferers on the road and the risk of antihistamine-related impairment is significant.

Safer Alternatives for Drivers

The good news is that hay fever can be managed effectively through routes that do not involve oral antihistamines at all. Nasal corticosteroid sprays, which are available over the counter under brand names such as Beconase, do not cause drowsiness and are recommended by the NHS as a first-line treatment for persistent hay fever. They are applied directly into the nose and their action is localised, meaning they do not enter the bloodstream in significant quantities and do not affect the central nervous system in the way oral antihistamines can.

Antihistamine eye drops are another option that avoids systemic effects. For drivers who need oral antihistamines, fexofenadine has the most consistent evidence for non-sedating effects and is one of the first-choice options for people who need to remain fully alert. However, even fexofenadine should be trialled on a non-driving day before being taken before a journey.

The general recommendation from pharmacists and road safety organisations is to try any new hay fever medication first on a day when you are not driving, ideally over a weekend or during time off. If the medication produces no drowsiness after several days of use, it is generally considered safer to take before driving, though drivers should remain alert to any change in how they feel.

Reading the Label Before You Drive

Every antihistamine product sold in the UK includes patient information about driving. The warnings vary depending on the specific formulation. First-generation antihistamines typically carry a clear warning advising against driving. Second-generation antihistamines usually include advice to check how the medication affects you individually before driving.

Some products include a specific warning about alcohol interaction. Combining alcohol with antihistamines, even second-generation formulations, significantly increases the risk of sedation and the likelihood of impairment. Drivers who have taken any antihistamine should be particularly cautious about alcohol consumption, even in small amounts.

The DVLA guidance on fitness to drive advises that drivers should always read the patient information leaflet for any medication and follow any advice about driving. Where a leaflet advises caution, the driver should treat that as a meaningful warning rather than a formality.

What to Do If You Are Affected While Driving

If a driver begins to feel drowsy behind the wheel, the action required is the same regardless of the cause. Stop as soon as it is safe to do so. If you are on a motorway or dual carriageway, use the nearest services or designated stopping area. Do not push on hoping the feeling will pass.

Research consistently shows that drowsiness at the wheel reduces reaction times in ways comparable to alcohol impairment, and that drivers often underestimate how impaired they are in the early stages. A driver who feels only slightly drowsy from antihistamines may have a reaction time significantly slower than they realise.

If you have taken hay fever medication and have any doubt about whether it is affecting your ability to drive safely, the answer is not to get behind the wheel. Arrange alternative transport, wait for the medication to wear off, or find a safe place to rest until you are confident you can drive safely. No destination is worth a prosecution, a ban or the risk of a collision.

Talking to a Pharmacist Before Allergy Season

Pharmacists are well placed to advise on which hay fever products are most appropriate for drivers. They can take a full medication history, identify any interactions with other drugs the driver takes, and recommend specific products with the lowest sedation risk for that individual.

This is a conversation that costs nothing and takes only a few minutes, but can significantly reduce the risk of inadvertently taking a medication that impairs driving ability. Many pharmacists actively offer medication reviews during allergy season, and NHS-affiliated pharmacies can provide this advice as part of routine consultations.

For drivers with particularly severe hay fever who find that standard non-prescription antihistamines are not managing their symptoms effectively, a GP can prescribe stronger formulations and advise on whether they are compatible with driving. Prescription options exist that offer more effective symptom control without the drowsiness risks associated with older over-the-counter products.